News >

PARP Inhibitors, Vaccines, and Combos Spark Excitement in mRCC

Jessica Hergert
Published: Thursday, Jan 09, 2020

Sumanta K. Pal, MD, of City of Hope

Sumanta K. Pal, MD

PARP inhibitors, CAR-based products, vaccines, and novel combination strategies are poised for introduction to the field of metastatic renal cell carcinoma (mRCC), said Sumanta Kumar Pal, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Publication Bottom Border
Border Publication